Forever Labs spins out SuperShot and appoints new chief executive

8 May 2025

US regenerative medicine firm Forever Labs has formally spun out SuperShot as a standalone business, a move the company says will allow both entities to sharpen their focus on growth and innovation.

Kevin Virgil has been appointed as the new chief executive of Forever Labs, replacing company co-founder Steven Clausnitzer, who will now lead SuperShot alongside co-founder Mark Katakowski. Both businesses will remain closely aligned, according to the announcement.

Mr Clausnitzer described the transition as “a natural evolution” and said SuperShot had matured to the point that “it deserves dedicated leadership and resources.” The move, he added, “sets the stage” for both companies to thrive independently while maintaining ties.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Biotechnology